Excellence in GLP-1 Agonists Purification: Robust Process Solutions
GLP-1 agonists have shown potential to treat diabetes and obesity, marking a significant breakthrough in peptide-based therapies. In this webinar, we’ll explore strategies to master GLP-1 agonists production, along with proven and robust technologies tailored for peptide therapeutics with a focus on GLP-1.
What You Will Learn:
- Discover the key features needed to optimize GLP-1 production.
- See how throughput and performance impact downstream processing in protein therapies.
- Learn how to maximize yield and purity with the right strategy for your process.